Clinical Trial Update: Phenomenological Explorations of the Esketamine-Induced Transient Dissociative State [NA]

View source ↗

Summary

A completed clinical trial investigating the phenomenology of the transient dissociative state induced by esketamine in individuals with depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• SPRAVATO (ESKETAMINE HYDROCHLORIDE)

Snippet

Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer | Conditions: Depressive Disorder | NA | Status: COMPLETED